Trials / Completed
CompletedNCT03617016
Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Prospective Pilot Study to Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Subjects With Functional Dyspepsia
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Xian-Janssen Pharmaceutical Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of the study is to assess the efficacy of domperidone in treatment of functional dyspepsia (FD) in Chinese participants and identify sub-populations (subtype of the disease) who are sensitive to domperidone treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Domperidone | Participants will receive domperidone tablets orally. |
| DRUG | Placebo | Participants will receive matching placebo to domperidone tablets orally. |
Timeline
- Start date
- 2018-08-27
- Primary completion
- 2020-07-31
- Completion
- 2020-07-31
- First posted
- 2018-08-06
- Last updated
- 2025-04-27
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03617016. Inclusion in this directory is not an endorsement.